Onoue Satomi, Tsuda Yoshiko
Analytical Research and Development, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi, 470-2393, Japan.
Pharm Res. 2006 Jan;23(1):156-64. doi: 10.1007/s11095-005-8497-9. Epub 2006 Nov 30.
Phototoxic responses after administration of photosensitive pharmaceutics have been recognized as undesirable side effects, and predicting potential hazardous side effects is gaining importance as new drugs are introduced to the market. In this work, we characterize the photochemical/photobiological properties of model compounds to develop an effective screening method for the prediction of phototoxic/photosensitive potential.
Twenty-one known photosensitive/phototoxic compounds and five weak/nonphototoxic compounds were subjected to ultraviolet (UV) spectral analyses and photochemical evaluation including the determination of produced reactive oxygen species (ROS) and photostability study. The photooxidation of linoleic acid was also monitored in the presence of tested compounds, guided on the formation of thiobarbituric acid reactive substances.
Most photosensitive/phototoxic drugs tested, even weak UV absorbers, at a concentration of 200 microM showed significant production of ROS under 18 h light exposure (30,000 lx). On the other hand, ROS generated from weak/nonphototoxic compounds, including strong UV absorber benzocaine, were low or negligible. Although exposure of quinine to light resulted in significant degradation (half-life, t1/2=6.4 h), it was dramatically attenuated by the addition of ROS scavengers, especially sodium azide (t1/2=122.6 h). Furthermore, concomitant exposure of photosensitive/phototoxic compounds (200 microM) and linoleic acid (1 mM) for 18 h led to the marked formation of lipoperoxide.
Results indicated that known photosensitive/phototoxic compounds tested have the ability to generate ROS under light exposure, and this photochemical reaction could be associated with their photoinstability and/or phototoxic responses. Based on these findings, determination of ROS, generated from photoirradiated compounds, may be an effective predictive model in recognizing their photosensitive/phototoxic potential.
服用光敏药物后的光毒性反应已被视为不良副作用,随着新药推向市场,预测潜在的有害副作用变得愈发重要。在本研究中,我们对模型化合物的光化学/光生物学特性进行表征,以开发一种有效的筛选方法来预测光毒性/光敏潜力。
对21种已知的光敏/光毒性化合物和5种弱/无光毒性化合物进行紫外(UV)光谱分析和光化学评估,包括测定产生的活性氧(ROS)以及光稳定性研究。在受试化合物存在的情况下,还通过硫代巴比妥酸反应性物质的形成来监测亚油酸的光氧化。
大多数受试的光敏/光毒性药物,即使是弱紫外线吸收剂,在浓度为200微摩尔时,在18小时光照(30,000勒克斯)下均显示出显著的ROS产生。另一方面,包括强紫外线吸收剂苯佐卡因在内的弱/无光毒性化合物产生的ROS较低或可忽略不计。尽管奎宁光照会导致显著降解(半衰期,t1/2 = 6.4小时),但通过添加ROS清除剂,尤其是叠氮化钠(t1/2 = 122.6小时),降解明显减弱。此外,光敏/光毒性化合物(200微摩尔)与亚油酸(1毫摩尔)同时暴露18小时会导致脂质过氧化物的显著形成。
结果表明,受试的已知光敏/光毒性化合物在光照下有产生ROS的能力,这种光化学反应可能与其光不稳定性和/或光毒性反应有关。基于这些发现,测定光辐照化合物产生的ROS可能是识别其光敏/光毒性潜力的有效预测模型。